ENGINEERING MEDICINES TO IMPROVE PATIENT CARE Investors SEC Filing Details Document Details Form 10-K Filing Date March 9, 2023 Document Date December 31, 2022 Form Description Annual report which provides a comprehensive overview of the company for the past year Filing Group Annual Filings Company Viridian Therapeutics Inc. Issuer VIRIDIAN THERAPEUTICS, INC.\DE Filing Formats iXBRL View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML - XBRL INSTANCE DOCUMENT
Document Details Form 10-K Filing Date March 9, 2023 Document Date December 31, 2022 Form Description Annual report which provides a comprehensive overview of the company for the past year Filing Group Annual Filings Company Viridian Therapeutics Inc. Issuer VIRIDIAN THERAPEUTICS, INC.\DE Filing Formats iXBRL View HTML Download PDF Download DOC Download XLS XBRL XBRL Viewer EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML - XBRL INSTANCE DOCUMENT